Bio Rad Laboratories Inc (NYSE:BIO)
| 753.02 Delayed Data As of 3:59pm ET |  -13.48 / -1.76%Today’s Change | 507.22 Today|||52-Week Range 832.70 | +29.18% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 545.1M | 617.5M | 554.0M | 572.6M | |
| Cost of Goods Sold | 223.5M | 249.3M | 199.0M | 222.0M | ||
| Depreciation And Amortization | 34.9M | 34.5M | 42.9M | 43.0M | ||
| Operating Expenses | Gross Income | 286.7M | 333.8M | 312.1M | 307.7M | |
| General Expenses | 255.0M | 265.3M | 255.7M | 251.2M | ||
| Research And Development | 49.7M | 53.1M | 47.6M | 50.0M | ||
| Total Operating Expenses | 513.5M | 549.1M | 497.6M | 516.1M | ||
| Non-Operating Expenses | Operating Income | 31.7M | 68.5M | 56.4M | 56.5M | |
| Extraordinary Credit | 322.6M | 0.00 | 1.1B | 716.4M | ||
| Extraordinary Charge | 0.00 | -814.4M | -1.9M | -100.0K | ||
| Interest Expense On Debt | 6.1M | 6.1M | 6.0M | 5.8M | ||
| Other Expenses | -687.0K | -294.5M | -484.0K | -1.1M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 350.1M | -1.0B | 1.1B | 769.6M | |
| Income Taxes | -80.8M | -213.4M | -262.1M | -170.8M | ||
| Net Income | 269.3M | -833.1M | 865.2M | 598.8M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 29.9M | 29.9M | 29.8M | 29.8M | |
| Shares To Calculate EPS Diluted | 30.3M | 29.9M | 30.1M | 30.2M | ||
| Earnings Per Share | EPS | $8.89 | -- | $28.74 | -- | |
| EPS Diluted | $8.89 | -$27.89 | $28.74 | $19.86 | ||
